Loading
Sentiment · FY2026 Q2
| Analyst | Firm | Questions (Challenge)Percentage of questions scored as challenging — where the analyst pushed back, pressed for specifics, or questioned management's assumptions. |
|---|---|---|
| Farrell Granath | Bank of America | 13 (0%) |
| Austin Wurschmidt | KeyBanc Capital Markets | 12 (0%) |
| Vikram Malhotra | Mizuho Securities | 11 (9%) |
| Omotayo Okusanya | Deutsche Bank | 10 (10%) |
| Rich Anderson | Cantor Fitzgerald | 10 (10%) |
| Ron Kamdem | Morgan Stanley | 10 (0%) |
| Mike Carroll | RBC Capital Markets | 10 (0%) |
| Wes Golladay | Robert W. Baird | 9 (0%) |
| Juan Sanabria | BMO Capital Markets | 9 (11%) |
| Michael Stroyeck | Green Street | 8 (13%) |
| Firm | Analysts | Questions (Challenge)Percentage of questions scored as challenging — where the analyst pushed back, pressed for specifics, or questioned management's assumptions. |
|---|---|---|
| Bank of America | 1 | 13 (0%) |
| BMO Capital Markets | 2 | 12 (8%) |
| Citigroup | 2 | 12 (0%) |
| Wells Fargo | 2 |
| 12 (0%) |
| Green Street | 2 | 12 (8%) |
| KeyBanc Capital Markets | 1 | 12 (0%) |
| Robert W. Baird | 2 | 11 (0%) |
| Mizuho Securities | 1 | 11 (9%) |
| Quarter | Revenue | Rev YoY | EPS | EPS YoY | Op margin | Net margin | FCF |
|---|---|---|---|---|---|---|---|
| FY2024 Q4 | $698M | +26.1% | $0.01 | -95.2% | 17.6% | 0.7% | $284M |
| FY2025 Q1 | $703M | +15.9% | $0.06 | +461.1% | 19.2% | 6.1% | $279M |
| FY2025 Q2 | $694M | -0.2% | $0.05 | -78.4% | 18.9% | 4.6% | $363M |
| FY2025 Q3 | $706M | +0.8% | $-0.17 | -241.7% | 18.7% | -16.6% | $288M |
| FY2025 Q4 | $719M | +3.1% | $0.16 | — | 20.3% | 15.8% | $294M |
| FY2026 Q1 | $753M | +7.1% | $0.28 | +362.0% | 15.5% | 25.7% | $237M |
| FY2026 Q2 | $772M | +11.1% | $0.08 | +76.2% | 16.2% | 8.2% | $0 |
Management’s own words, often on a non-GAAP, constant-currency, or adjusted basis — so these can differ from the GAAP figures above (e.g. constant-currency revenue growth excludes currency swings).
DOC posted FFO as adjusted of $0.45 per share with lab occupancy inflecting upward to 77.7% on a broad pipeline, as the Janus Living IPO was completed at a 20-turn premium and a Blackstone outpatient JV at a 6.1% cap rate validated private market value. FFO guidance was raised to $1.71-1.75 on buyback accretion, while outpatient medical sustained strength with 5.4% re-leasing spreads and capital recycling progressed toward the $1 billion target.
Demand | Capital Allocation | Capex Investment | M&A | Competitive Dynamics | Guidance Reliability | Credit | Revenue Growth | |
|---|---|---|---|---|---|---|---|---|
| 2024Q4 | 10 | 8 | 10 | 4 | 4 | 3 | 3 | |
| 2025Q1 | 11 | 3 | 11 | 2 | 5 | 3 | ||
| 2025Q2 | 12 | 4 | 2 | 2 | 3 | 1 | 6 | 1 |
| 2025Q3 | 12 | 11 | 2 | 2 | 1 | 1 | 1 | |
| 2025Q4 | 11 | 5 | 3 | 6 | 1 | 5 | 1 | |
| 2026Q1 | 6 | 4 | 1 | 3 | 3 | 3 | 2 |
| '24Q4 | '25Q1 | '25Q2 | '25Q3 | '25Q4 | '26Q1 | |
|---|---|---|---|---|---|---|
| Demand | 10 | 11 | 12 | 12 | 11 | 6 |
| Capital Allocation | 8 | 3 | 4 | 11 | 5 | 4 |
| Capex Investment | 10 | 11 | 2 | 2 | 3 | 1 |
| M&A | 4 | 2 | 2 | 6 | 3 | |
| Competitive Dynamics | 4 | 2 | 3 | 1 | 1 | 3 |
| Guidance Reliability | 3 | 1 | 1 | 5 | 3 | |
| Credit | 5 | 6 | 1 | 1 | ||
| Revenue Growth | 3 | 3 | 1 | 2 |
What DOC and other companies said about each other on FY2026 Q1 earnings calls — extracted verbatim from public transcripts. Mentions from the newest quarter are a Pro feature.
“we now have Hines partnering with us on the multifamily opportunity.”
Healthpeak brought in Hines to lead the multifamily/residential half of its ~5M sq ft mixed-use Alewife project in Cambridge.
“this outcome was achieved through direct negotiations with Baylor and McKesson, leveraging decades-long relationships and in-house operating platform”
Healthpeak negotiated the Baylor cancer-center lease renewals directly with Baylor and McKesson, indicating McKesson's involvement (US Oncology) as a party in the outpatient oncology real estate.
“several large renewals with leading health system partners, including Baylor Scott & White, Norton Health and HCA.”
Baylor Scott & White is a leading health-system tenant that renewed large outpatient leases with Healthpeak, including a 458,000 sq ft Dallas cancer-center campus.
“several large renewals with leading health system partners, including Baylor Scott & White, Norton Health and HCA.”
HCA is named among the leading health-system tenants that signed large outpatient-medical lease renewals with Healthpeak this quarter.
“In March, we closed a joint venture recap with Blackstone on a fully occupied outpatient portfolio at a 6.1% cash cap rate.”
Healthpeak closed a JV recap with Blackstone on a fully occupied outpatient medical portfolio at a 6.1% cap rate and calls it a template for future recaps/acquisitions, a read-through for Blackstone's healthcare real estate appetite.
| Company | Score | Trend | Rev YoY |
|---|---|---|---|
DOC Healthpeak Properties | 6 | +7.1% | |
| VTR Ventas | 8 | +22.0% | |
| WELL Welltower | 8 | +38.4% |